SERGES MEDICALS
a division of
SERGES S.A.
a private limited company incorporated in BELGIUM
(BCE 0425.088.939)
Avenue de Tervuren, 148, bte25
B – 1150 Brussels
For further informations, appointments or any question, please contact us by e-mail or phone. Serges Medicals is located in Brussels, Belgium.
You can contact us by e-mail during office hours, we will reply as quick as possible.
By a long shareholders familial tradition, SERGES is concerned by TUBERCULOSIS and CANCER. When the company meets industrials creating new technologies that can bring relief to people, avoiding or reducing effective dangers, it decides to assist those manufacturers.
In this case, we are pooling worldwide, the trade of DIGIPORT-X, a mobile radiography unit manufactured by MEDIXBEL S.A.(go to website), a Belgian company established in Loncin (Belgium).
DIGIPORTX is a whole solution to make fast moving units for governments and medical authorities in countries with geographical particularities creating uneasy-to-reach populations.
People can easily move around it. Dimensions: Stand is 849mm * 1542mm + cases (mechanical, electronic modules, computer & detector). Only 110kg!
The operator can stay up to 2m behind the X-Ray generator focus and people waiting for a radiography can stay in a different room or at least at 10m away from the X-Ray generator.
DigiportX is made for children X-ray diagnosis too.
DigiportX is deployed in only 15 minutes by 3 people.
Tuberculosis (TB) is one of the top 10 causes of death worldwide.In 2015, 10.4 million people fell ill with TB and 1.8 million died from the disease (including 0.4 million among people with HIV). Over 95% of TB deaths occur in low- and middle-income countries.
Six countries account for 60% of the total, with India leading the count, followed by Indonesia, China, Nigeria, Pakistan and South Africa.
In 2015, an estimated 1 million children became ill with TB and 170 000 children died of TB (excluding children with HIV). TB is a leading killer of HIV-positive people: in 2015, 35% of HIV deaths were due to TB. Globally in 2015, an estimated 480 000 people developed multidrug-resistant TB (MDR-TB).
TB incidence has fallen by an average of 1.5% per year since 2000. This needs to accelerate to a 4–5% annual decline to reach the 2020 milestones of the “End TB Strategy”. An estimated 49 million lives were saved through TB diagnosis and treatment between 2000 and 2015.
Ending the TB epidemic by 2030 is among the health targets of the newly adopted Sustainable Development Goals.
WHO Statistics
DigiportX is a MedixBel product distributed exclusively by Serges Medicals in the world. It is a transportable direct digital x-ray imaging system. It uses the DR flat panel technology. It is used for conventional x-ray diagnosis in RAD for tuberculosis (TB) and other standard exams. Up to 200 exams per day. Average of 20.000 / year.
We will answer any message as fast as possible.
henri.frelinx@frelinx.com
